KALA
KALA
NASDAQ · Biotechnology

Kala Bio Inc

$3.05
-0.04 (-1.29%)
As of May 16, 2:30 AM ET ·
Financial Highlights (FY 2025)
Revenue
4.88M
Net Income
-169,945
Gross Margin
45.1%
Profit Margin
-3.5%
Rev Growth
-8.5%
D/E Ratio
0.77
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 45.1% 45.1% 45.1%
Operating Margin -2.9% -3.2% -3.0%
Profit Margin -3.5% -3.8% -3.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.88M 4.46M 5.44M
Gross Profit 2.20M 2.01M 2.45M
Operating Income -140,532 -141,326 -163,852
Net Income -169,945 -168,167 -171,039
Gross Margin 45.1% 45.1% 45.1%
Operating Margin -2.9% -3.2% -3.0%
Profit Margin -3.5% -3.8% -3.2%
Rev Growth -8.5% +21.3% +21.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.06M 5.80M 6.56M
Total Equity 7.87M 9.08M 8.18M
D/E Ratio 0.77 0.64 0.80
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -214,177 -200,655 -244,682
Free Cash Flow -155,731 -123,018 -136,236